On the other hand, TET2/SRSF2 mutations were only found in 19%/1% of PV patients without monocytosis as compared to 57%/29% in PV patients with monocytosis ≥ 1 × 109/L [1]. This evidence concerns the gene TET2 and acquired polycythemia vera.